Device
tinnitus retraining therapy
tinnitus retraining therapy is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph phase_1
1
33%
Ph not_applicable
1
33%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus
NCT07469969
completedphase_2
Evaluation of Treatment Methods for Clinically Significant Tinnitus
NCT00013390
completedphase_1
The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus
NCT00124800
Clinical Trials (3)
Showing 3 of 3 trials
NCT07469969Not Applicable
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus
NCT00013390Phase 2
Evaluation of Treatment Methods for Clinically Significant Tinnitus
NCT00124800Phase 1
The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3